All Type of News
Korea Pharmaceutical Ind. Coop’s Joint Testing Center opens
The Korea Pharmaceutical Ind. Coop.(Chairman Yong-Jun Cho, CEO of Dongkoo Bio&Pharma), announced acquisition of approval from the Ministry of Food and Drug Safety(MFDS) for the ‘Joint Testing Center’ that the company ...
‘No sanitary pad in the market is harmful to human body’
The Ministry of Food and Drug Safety(MFDS) conducted a total inspection and harm evaluation about 10 VOCs(Volatile Organic Compounds) with a high human body risk on sanitary pads in the market, and the inspections sho...
Dong-A Socio, Alteogen & DMBio signs contract service agreement of macular degeneration treatment
Alteogen(CEO Soon-Jae Park), a company which are developing a biosimilar of macular degeneration treatment ‘Eylea,’ announced on the 28th that it signed a Eylea biosimilar manufacturing agreement with DMBio(Byung-Jo M...
Aprogen’s ‘Remicade’ biosimilar break into KRW 1 trillion Japanese market
A ‘Remicade’ biosimilar developed by Aprogen has made a stepping stone to enter the KRW 1 trillion Japanese market.
Aprogen(CEO Jae-Seop Kim), a biosimilar company, announced the company acquired approval of its Remi...
More emergency household medicine selling stores than pharmacies
It was surveyed that there are more stores selling emergency household medicines than pharmacies in Korea.
According to the Ministry of Health and Welfare, the number of emergency household medicine sellers was total...
Sudden decrease of bioequivalently approved medicines by 54% year-on-year
There were 481 medicines newly approved by bioequivalence test this year, which was decreased by more than half compared to the same period of the last year.
According to the Ministry of Food and Drug Safety(MFDS), t...
Distribution industry getting tense over launches of generics, like Viread and Dexid
Pouring generic medicines produced by patent expiration of large products, such as Tamiflu, have troubled pharmaceutical distribution companies in the 2nd half of the year.
For your information, a number of Tamifly g...
Celltrion selects ‘Oracle’ technology to smoothly manage drug side effects
Oracle announced on the 26th(U.S. local time) that Celltrion chose ‘Oracle Health Sciences Argus’ and ‘Oracle Health Sciences Empirica Signal’ to launch life-saving chronic disease treatments more and cheaper by contr...
Ilyang Pharmaceutical’s Supect shows high generic response than Glivec
A phase III clinical trial result of ‘Supect(radotinib),’ the Asia’s first leukemia treatment developed by Ilyang Pharmaceutical, was published an online-version of an international journal ‘Clinical Cancer Research,’...
7 of 10 license-using pharmacists were female in Seoul
6 of 10 license-using pharmacists(pharmacists who actually use pharmacist license for work) were reportedly a female pharmacist.
Moreover, farming and fishing areas had a higher ratio of male pharmacists, and urban a...
